Novel Device for Inhaled Drugs

• Design and validation of device.
• Clinical trials in humans for semi-regulated markets.
• Launch in semi-regulated markets in 2009.

Gastro Retentive Innovative Device (GRID)

• Launch Baclofen GRS in India or which phase I, II & III clinical trials in humans have been completed and approval has been received.
• IND filing with US FDA.

Wrap Matrix System

• Launch controlled release products based on wrap matrix technology after approval is obtained for the ANDA’s that Sun Pharma has filed with US FDA, To develop innovative products based on this technology, take through clinical trials and file these products.

Nanoemulsion

• To complete technology development for two cytotoxic products that are being studied.

Biodegradable Injections / Implants

• Complete the ongoing clinical trials in humans in India for depot injection for somatostatin, and eventually launch the product.
• Complete preclinical studies for depot injection of GnRH analogue that is being developed. Likely take it for clinical trials in humans.

Disclaimer : these are high risk projects and face uncertain timelines.